Ivan Van Riet

7.6k total citations · 1 hit paper
130 papers, 5.4k citations indexed

About

Ivan Van Riet is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Ivan Van Riet has authored 130 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Hematology, 56 papers in Oncology and 43 papers in Molecular Biology. Recurrent topics in Ivan Van Riet's work include Multiple Myeloma Research and Treatments (62 papers), Immunotherapy and Immune Responses (24 papers) and Cell Adhesion Molecules Research (22 papers). Ivan Van Riet is often cited by papers focused on Multiple Myeloma Research and Treatments (62 papers), Immunotherapy and Immune Responses (24 papers) and Cell Adhesion Molecules Research (22 papers). Ivan Van Riet collaborates with scholars based in Belgium, United States and France. Ivan Van Riet's co-authors include Karin Vanderkerken, Ann De Becker, Ben Van Camp, Benjamin Van Camp, Kewal Asosingh, Kris Thielemans, M. De Waele, Isabelle Vande Broek, Carlo Heirman and Eline Menu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ivan Van Riet

127 papers receiving 5.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

2016 377 citations Ann De Becker, Ivan Van Riet World Journal of Stem Cells profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ivan Van Riet	2.4k	2.4k	2.1k	1.2k	1.2k	130	5.4k
Robert Möhle	2.3k 0.9×	2.5k 1.1×	2.1k 1.0×	1.6k 1.4×	1.5k 1.2×	82	6.3k
Jean-Pierre Lévesque	4.2k 1.7×	2.4k 1.0×	2.1k 1.0×	3.2k 2.7×	1.7k 1.4×	158	8.5k
Virginia C. Broudy	1.7k 0.7×	2.0k 0.8×	1.3k 0.6×	1.2k 1.0×	727 0.6×	32	4.8k
Ian McNiece	3.2k 1.3×	2.7k 1.1×	1.6k 0.8×	1.9k 1.6×	2.9k 2.5×	133	8.2k
Ryan Reca	953 0.4×	3.3k 1.4×	1.5k 0.7×	1.6k 1.4×	1.4k 1.2×	43	6.0k
Reinhard Henschler	1.1k 0.4×	1.7k 0.7×	870 0.4×	758 0.6×	1.7k 1.5×	138	4.7k
Susan K. Nilsson	2.6k 1.1×	1.7k 0.7×	1.0k 0.5×	1.4k 1.2×	1.5k 1.3×	96	5.2k
Izhar Hardan	1.6k 0.7×	1.1k 0.5×	1.6k 0.8×	1.2k 1.0×	728 0.6×	93	4.4k
Mark J. Kiel	3.1k 1.3×	2.9k 1.2×	1.7k 0.8×	2.0k 1.7×	1.5k 1.3×	37	7.2k
M Valtieri	1.9k 0.8×	3.6k 1.5×	1.0k 0.5×	1.2k 1.0×	1.2k 1.0×	86	6.0k

Countries citing papers authored by Ivan Van Riet

Since Specialization

Citations

This map shows the geographic impact of Ivan Van Riet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Van Riet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Van Riet more than expected).

Fields of papers citing papers by Ivan Van Riet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Van Riet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Van Riet. The network helps show where Ivan Van Riet may publish in the future.

Co-authorship network of co-authors of Ivan Van Riet

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Van Riet. A scholar is included among the top collaborators of Ivan Van Riet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Van Riet. Ivan Van Riet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ridder, Kirsten De, Yanina Jansen, Ann De Becker, et al.. (2024). The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis. Frontiers in Immunology. 15. 1397469–1397469. 1 indexed citations

Ilsen, Bart, Frederik Vandenbroucke, Ramses Forsyth, et al.. (2024). A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors. Cancer Immunology Immunotherapy. 73(9). 167–167. 2 indexed citations

Dufait, Inès, Julia Katharina Schwarze, Ivan Van Riet, et al.. (2021). Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells. Frontiers in Immunology. 12. 733506–733506. 7 indexed citations

Becker, Ann De & Ivan Van Riet. (2016). Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?. World Journal of Stem Cells. 8(3). 73–73. 377 indexed citations breakdown →

Wilgenhof, Sofie, An M. T. Van Nuffel, Daphné Benteyn, et al.. (2013). A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. Annals of Oncology. 24(10). 2686–2693. 170 indexed citations

Xu, Song, Kim De Veirman, Holly Evans, et al.. (2013). Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacologica Sinica. 34(5). 699–709. 50 indexed citations

Braakman, E, Gerrit‐Jan Schuurhuis, Frank Preijers, et al.. (2008). Evaluation of ‘out-of-specification’ CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products. Cytotherapy. 10(1). 83–89. 7 indexed citations

Schots, Rik, Gilles W. De Keulenaer, Danny Schoors, et al.. (2007). Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure. Experimental Hematology. 35(12). 1884–1890. 31 indexed citations

Becker, Ann De, Paul Van Hummelen, Marleen Bâkkus, et al.. (2007). Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica. 92(4). 440–449. 187 indexed citations

10.

Snykers, Sarah, Tamara Vanhaecke, Peggy Papeleu, et al.. (2006). In vitro multipotency of human bone marrow (mesenchymal) stem cells. VUBIR (Vrije Universiteit Brussel). 22. 400–405. 2 indexed citations

11.

Menu, Eline, Evy De Leenheer, Hendrik De Raeve, et al.. (2006). Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clinical & Experimental Metastasis. 23(5-6). 291–300. 90 indexed citations

12.

Caers, Jo, Kewal Asosingh, Ben Van Camp, Ivan Van Riet, & Karin Vanderkerken. (2004). Of mice and men, disease models of multiple myeloma.. Open Repository and Bibliography (University of Liège). 1 indexed citations

13.

Valckenborgh, Els Van, Peter I. Croucher, Hendrik De Raeve, et al.. (2004). Multifunctional role of matrix metalloproteinases in multiple myeloma: study in the 5T2mm mouse model.. VUBIR (Vrije Universiteit Brussel). 1 indexed citations

14.

Riet, Ivan Van, et al.. (2001). A systemic inflammatory response involving C-Reactive Protein, Interleukin-6, Interleukin-8 and Tumor Necrosis Factor-alpha contributes to the development of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.. Blood. 98(11). 1 indexed citations

15.

Broek, Isabelle Vande, Karin Vanderkerken, Nicole Straetmans, Benjamin Van Camp, & Ivan Van Riet. (2000). The chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates chemotaxis to monocyte chemotactic proteins MCP-1, 2 and 3.. Blood. 96(11). 5 indexed citations

16.

Vanderkerken, Karin, Els Van Valckenborgh, Marleen Bâkkus, et al.. (2000). Bone marrow microenvironmental-induced upregulation of MMP-9 activity in murine multiple myeloma cells. Clinical & Experimental Metastasis. 17(9). 2 indexed citations

17.

Riet, Ivan Van, Karin Vanderkerken, Catherine De Greef, & Ben Van Camp. (1998). Homing behaviour of the malignant cell clone in multiple myeloma. Medical Oncology. 15(3). 154–164. 25 indexed citations

18.

Vanderkerken, Karin, Hendrik De Raeve, E Goes, et al.. (1997). Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. British Journal of Cancer. 76(4). 451–460. 120 indexed citations

19.

Riet, Ivan Van, Nadine Juge‐Morineau, Rik Schots, et al.. (1997). Persistence of residual tumour cells after cytokine‐mediated ex vivo expansion of mobilized CD34⁺ blood cells in multiple myeloma. British Journal of Haematology. 96(2). 403–411. 9 indexed citations

20.

Bâkkus, Marleen, et al.. (1995). The Clonogenic Precursor Cell in Multiple Myeloma. Leukemia & lymphoma. 18(3-4). 221–229. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact